Overview
Current NAV
9.9500
As on 30-Dec-2025
Fund Size
99.701 Cr
Managed by Puneet Pal
Expense Ratio
0.65%
Latest reported
Exit Load Rules
0
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 06-Dec-2024. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.60 | — | — | — |
| 1W | -1.29 | — | — | — |
| 1M | -3.02 | — | — | — |
| 3M | 2.89 | — | 1.47 | — |
| 6M | 0.20 | — | 0.20 | — |
| 1Y | -1.18 | — | -2.14 | — |
| 3Y | — | — | 22.11 | — |
| 5Y | — | — | 14.61 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
11.72
Divi's Laboratories Ltd.
EQ
Healthcare
9.97
Max Healthcare Institute Ltd.
EQ
Healthcare
7.21
Aster DM Healthcare Ltd.
EQ
Healthcare
6.23
Dr. Reddy's Laboratories Ltd.
EQ
Healthcare
6.01
JB Chemicals & Pharmaceuticals Ltd.
EQ
Healthcare
5.11
Mankind Pharma Ltd.
EQ
Healthcare
4.65
Rubicon Research Ltd.
EQ
Healthcare
4.29
Ajanta Pharma Ltd.
EQ
Healthcare
3.92
Abbott India Ltd.
EQ
Healthcare
3.61
Krishna Institute of Medical Sciences Ltd
EQ
Healthcare
3.46
PB Fintech Ltd.
EQ
Services
2.89
Analysis Highlights
PROS
Lower expense ratio: 0.65%
PROS
1Y annualised returns higher than category average by 0.96%